Real-time enrollment status for this connective tissue diseases clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:29 AM UTC
| NCT Number | NCT06716606 |
| Recruiting Status | Recruiting |
| Condition | Connective Tissue Diseases |
| Phase | PHASE3 |
| Target Enrollment | 514 participants |
| Active Locations | 1 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | December 9, 2025 (Dec 9, 2025) |
As of July 17, 2026: Clinical trial NCT06716606 is currently recruiting participants. This phase3 study for connective tissue diseases is actively seeking new participants at 1 location across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06716606 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06716606 was last updated Dec 9, 2025 (December 9, 2025). HelloStudys verifies this status automatically.